Cognitive functions in long-term survivors of ovarian cancer. (Q51045304)

27 March 2018

title

Cognitive functions in long-term survivors of ovarian cancer. (English)

1 reference

27 March 2018

1 reference

Denise D Correa

1

1 reference

27 March 2018

Qin Zhou

2

1 reference

27 March 2018

Howard T Thaler

3

1 reference

27 March 2018

Michelle Maziarz

4

1 reference

27 March 2018

Karen Hurley

5

1 reference

27 March 2018

Martee L Hensley

6

1 reference

27 March 2018

language of work or name

English

0 references

publication date

14 July 2010

1 reference

27 March 2018

published in

Gynecologic Oncology

1 reference

27 March 2018

volume

119

1 reference

27 March 2018

issue

2

1 reference

27 March 2018

page(s)

366-369

1 reference

27 March 2018

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

Cognitive function in breast cancer patients receiving adjuvant chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

Cognitive function in breast cancer patients prior to adjuvant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: pathologic complete response and longitudinal assessment of impact on cognitive functioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

Frequency and bases of abnormal performance by healthy adults on neuropsychological testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

Neurotoxicity secondary to antineoplastic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

Candidate mechanisms for chemotherapy-induced cognitive changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

Prophylactic oophorectomy in premenopausal women and long-term health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.023

10.1016/J.YGYNO.2010.06.023

7 January 2021

Identifiers

DOI

1 reference

27 March 2018

PubMed ID

20630576

1 reference

27 March 2018